Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Luveltamab Tazevibulin L-phenylalanine Drug Linker(2)
1. Luveltamab Tazevibulin
| Molecular Weight | 1387.6 g/mol |
|---|---|
| Molecular Formula | C74H94N14O13 |
| XLogP3 | 2.3 |
| Hydrogen Bond Donor Count | 11 |
| Hydrogen Bond Acceptor Count | 17 |
| Rotatable Bond Count | 32 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 394 |
| Heavy Atom Count | 101 |
| Formal Charge | 0 |
| Complexity | 2850 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 6 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
75
PharmaCompass offers a list of Luveltamab Tazevibulin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Luveltamab Tazevibulin manufacturer or Luveltamab Tazevibulin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Luveltamab Tazevibulin manufacturer or Luveltamab Tazevibulin supplier.
PharmaCompass also assists you with knowing the Luveltamab Tazevibulin API Price utilized in the formulation of products. Luveltamab Tazevibulin API Price is not always fixed or binding as the Luveltamab Tazevibulin Price is obtained through a variety of data sources. The Luveltamab Tazevibulin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Luveltamab Tazevibulin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Luveltamab Tazevibulin, including repackagers and relabelers. The FDA regulates Luveltamab Tazevibulin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Luveltamab Tazevibulin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Luveltamab Tazevibulin supplier is an individual or a company that provides Luveltamab Tazevibulin active pharmaceutical ingredient (API) or Luveltamab Tazevibulin finished formulations upon request. The Luveltamab Tazevibulin suppliers may include Luveltamab Tazevibulin API manufacturers, exporters, distributors and traders.
Luveltamab Tazevibulin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Luveltamab Tazevibulin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Luveltamab Tazevibulin GMP manufacturer or Luveltamab Tazevibulin GMP API supplier for your needs.
A Luveltamab Tazevibulin CoA (Certificate of Analysis) is a formal document that attests to Luveltamab Tazevibulin's compliance with Luveltamab Tazevibulin specifications and serves as a tool for batch-level quality control.
Luveltamab Tazevibulin CoA mostly includes findings from lab analyses of a specific batch. For each Luveltamab Tazevibulin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Luveltamab Tazevibulin may be tested according to a variety of international standards, such as European Pharmacopoeia (Luveltamab Tazevibulin EP), Luveltamab Tazevibulin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Luveltamab Tazevibulin USP).
